검색어 : 통합검색[Cancer drug discovery and development]
총 10,586건 중 1,000건 출력
, 91/100 페이지
-
901
- Drug Repurposing and Nanotechnology for Topical Skin Cancer Treatment: Redirecting toward Targeted and Synergistic Antitumor Effects
- Martins, Maria; Veiga, Francisco; Paiva-Santos, Ana Clá udia; Pires, Patrí cia C.; Department of Pharmaceutical Technology , Faculty of Pharmacy of the University of Coimbra, University of Coimbra , Azinhaga de Santa Comba , 3000-548 Coimbra , Portugal; Department of Pharmaceutical Technology , Faculty of Pharmacy of the University of Coimbra, University of Coimbra , Azinhaga de Santa Comba , 3000-548 Coimbra , Portugal; (Acs pharmacology & translational science, v.8, 2025, pp.308-338)
-
902
- Triplicate Dynamic Cell Culture Platform for Enhanced Reproducibility in Anti-Cancer Drug Testing
- Lu, Yu-Lun; Lin, Chiao-Min; Huang, Jen-Huang; Department of Chemical Engineering , National Tsing Hua University , Hsinchu 30013 , Taiwan; Department of Chemical Engineering , National Tsing Hua University , Hsinchu 30013 , Taiwan; (ACS biomaterials science & engineering, v.11, 2025, pp.1222-1231)
-
903
- Real-Time NMR-Based Drug Discovery to Identify Inhibitors against Fatty Acid Synthesis in Living Cancer Cells
- Liu Biao; Liu Caixiang; Chai Xin; Fan Xinyu; Huang Tao; Zhan Jianhua; Zhu Qinjun; Zeng Danyun; Gong Zhou; Yang Yunhuang; Xin Zhou; Jiang Bin; Zhang Xu; Liu Maili; Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; Innovation Academy for Precision Measurement of Science and Technology, Chinese Academy of Sciences; (, v., 2023, )
- 904.
-
905
- Platelet-activating factor podoplanin: from discovery to drug development
- Takemoto, Ai; Miyata, Kenichi; Fujita, Naoya; Division of Experimental Chemotherapy, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550 Japan; Division of Experimental Chemotherapy, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550 Japan; Division of Experimental Chemotherapy, The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550 Japan; (Cancer and metastasis reviews, v.36, 2017, pp.225-234)
-
906
- TIPE3 promotes drug resistance in colorectal cancer by enhancing autophagy via the USP19/Beclin1 pathway
- Chen, Chun; Jin, Longyang; Wan, Hong; Liu, Hu; Zhang, Shuping; Shen, Gang; Gong, Jiao; Zhu, Yong; ; (Cell death discovery, v.11, 2025, pp.202)
-
907
- Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK)
- Kong, Xiaotian; Pan, Peichen; Sun, Huiyong; Xia, Hongguang; Wang, Xuwen; Li, Youyong; Hou, Tingjun; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , Zhejiang 310058 , China; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , Zhejiang 310058 , China; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , Zhejiang 310058 , China; Department of Biochemistry & Research Center of Clinical Pharmacy of the First Affiliated Hospital , Zhejiang University , Hangzhou 310058 , China; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences , Zhejiang University , Hangzhou , Zhejiang 310058 , China; Institute of Functional Nano and Soft Materials (FUNSOM) , Soochow University , Suzhou , Jiangsu 215123 , China; (Journal of medicinal chemistry, v.62, 2019, pp.10927-10954)
-
908
- CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells
- Arias Cardenas, Kelly C.; Enos, Clinton W.; Spear, Mark R.; Austin, Dana E.; Almofeez, Raghad; Kortchak, Stephanie; Pincus, Lauren; Guo, Hua-bei; Dolezal, Samuel; Pierce, J. Michael; Furth, Emma; Gineste, Cyrille; Kwon, Yongjun; Gelber, Cohava; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA; Eastern Virginia Medical School, Norfolk, Virginia, USA; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA; Stromatis Pharma, 9501 Discovery Blvd Manassas, VA 20109, USA; University of Georgia Cancer Center, Department of Biochemistry and Molecular Biology and the Complex Carbohydrate Research Center (CCRC), USA; University of Georgia Cancer Center, Department of Biochemistry and Molecular Biology and the Complex Carbohydrate Research Center (CCRC), USA; University of Georgia Cancer Center, Department of Biochemistry and Molecular Biology and the Complex Carbohydrate Research Center (CCRC), USA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA; Vaxxinity Inc, Merritt Island, Fl, USA; (Current cancer drug targets, v.24, 2024, pp.720-732)
-
909
- Repurposing FDA-Approved Anastrozole-based Drugs for Breast Cancer through Drug-Drug Transcriptomic Similarity and Cavity Detection Guided Blind Docking
- Mujawar, Tabjez; Tare, Harshal; Deshmukh, Nitin; Udugade, Babaso; Thube, Ujjwala; ; (International journal of drug delivery technology, v.13, 2023, pp.1172-1177)
-
910
- [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept]
- Shirasaka, Tetsuhiko; Taguchi, Tetsuo; ; (癌と化學療法 = Cancer & chemotherapy, v.33, 2006, pp.4-18)
QUICK MENU
